Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
May 29 2024 - 4:05PM
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company
leveraging novel next-generation sequencing (NGS) and spatial
multiomics technologies to empower researchers and clinicians,
today announced plans to present at the Goldman Sachs 45th Annual
Global Healthcare Conference in Miami, Florida.
Singular Genomics’ management is scheduled to
participate in a fireside chat Wednesday, June 12, 2024, at 7:40
a.m. Pacific Time / 10:40 a.m. Eastern Time. Investors and other
interested parties are invited to listen to a live and recorded
webcast of the presentation at investor.singulargenomics.com in the
Presentations & Events section.
About Singular Genomics Systems, Inc.Singular
Genomics is a life science technology company that develops
next-generation sequencing and multiomics technologies. The
commercially available G4® Sequencing Platform is a powerful,
highly versatile benchtop genomic sequencer designed to produce
fast and accurate results. In addition, the company is currently
developing the G4X™ Spatial Sequencer, which will leverage
Singular’s proprietary sequencing technology, applying it as an in
situ readout for transcriptomics, proteomics and fluorescent
H&E in tissue, with spatial context and on the same platform as
the G4. Singular Genomics’ mission is to empower researchers and
clinicians to advance science and medicine. Visit
www.singulargenomics.com for more information.
Investor ContactPhilip Trip TaylorGilmartin
Groupir@singulargenomics.com
Media ContactMatt
Browningpr@singulargenomics.com
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
From Oct 2023 to Oct 2024